Embed Size (px)
Citation preview
Innovations in pharmaceutical developmentEurope’s premier drug delivery and formulation event
Post Event Reportwww.ddfevent.com
11 - 13 March 2019 | Berlin
10th Global
said the summit met, exceeded or greatly exceeded their expectations
99%
learned something new and useful for
their work
96%
would attend again
96%
would recommend
the summit to a colleague
98%
met somebody who could help
with their current challenges
84%
Statistics
registered attendees
Over
400companiesand organisationsrepresented
231Highlights video
2
11 - 13 March 2019 | Berlin
10th Global
The perfect mix. The 3-day agenda was split into four dedicated streams of sessions – Small Molecules, Biologics, Technology & Innovation and Device Development. This allowed attendees to pick and choose the specific topics most interesting to them.
Here’s some of what was covered this year:
Key themes
Small Molecules Stream
• Optimisation of freeze-drying processes• Latest in nanoparticle formulation• Updates in granulation processes• Inhalable dry powders• Overcoming poor solubility • Exploring 3D printing• Transmucosal delivery
Biologics Stream• Next generation biologics• In-silico modelling• High-throughput formulations• Oral peptide delivery• Electrospinning of biopharmaceuticals• Overcoming the blood brain barrier
Technology & Innovation• Sustained release of peptides• 2D inkjet printing of formulations• Fillandfinishprocesses• High protein concentration formulations• Digital design of pharmaceutical products and processes• Regulations for patient-centric drug development
Device Development• Patient centric delivery device development• Sustained transdermal drug delivery• Packaging development• Combination products• MDR impact• Human factors• Device lifecycle management
“A variety of content and lots of useful,
practical information”ChiaChen Chen, Manager of Pharmaceutical Development,
ScinoPharm Taiwan
3
11 - 13 March 2019 | Berlin
10th Global
“One of the largest and best platforms to bring together large Pharma with
advanced CROs/CMOs as well as latest developments in Academia”
Stefan Bracht, Head of Disruptive Technology, Bayer
“Informative. Inspiring. Well organized. Felt spoiled (all those
breaks and lunches). To the point. Delivering as promised”
Iulia Oita, Stability Manager, Ablynx
“Cross active meeting, nice balance between Combination Product and Biologics, very engaging and very good case studies”
Kerstin Walke, Head Pharmaceutical Development, Boehringer Ingelheim
“Very interesting talks. The summit well organized. Amazing experience”
Giulio Cavalli, Process Scientist, Chiesi Ltd
“Lot of presentation with high quality, variety of topics, great chance for networking”
Hanna Kuśmierek, Site Manager, Janssen and Cilag
“Very good. Excellent breadth of presentations. Good representation
from both industry and academia”David Churchley, Pharmaceutical Development
Manager, ECO Animal Health
“Well organized, comfortable space, interesting sessions, good
networking opportunities”Mark Howansky, Associate Director, Device
Development, Bristol Myers Squibb
“Great range of high-quality speakers, comfortable venue and very well organised”David Harrison, Senior Alliance Lead, UCB Biopharma
What did the attendees think?
4
11 - 13 March 2019 | Berlin
10th Global
Explore the content – Small MoleculesClick on the buttons below to view the presentation slides.
CrystallizationkineticsinASDs
DDFSummit|March13th 2019 | Berlin
ChristianLuebbert,GabrieleSadowski
LaboratoryofThermodynamics
Smart delivery of actives by polyrotaxanesproviding new options for the treatment of
Niemann Pick Type C disease
Kerstin Egele1, Shayak Samaddar², David Thompson², Gerhard Wenz1
1 Organic Macromolecular Chemistry, Saarland University, Germany² Purdue University, Lafayette, USA
Berlin, 13 March 2019
Polyoxazoline:A potent alternative to PEG-basedformulations of hydrophobic drugs
Rainer JordanChair of Macromolecular Chemistry, TU Dresden, Germany& DelAqua Pharmaceuticals Inc., USA
Robert LuxenhoferFunctional Polymer Materials, Universität Würzburg, Germany& DelAqua Pharmaceuticals Inc., USA
Alexander V. KabanovCenter for Nanotechnology in Drug Delivery, University of North Carolina at Chapel Hill, USA& DelAqua Pharmaceuticals Inc., USA
1
Importance of establishing the stability of drug-loaded nanoparticles
Dr. Cornelus F. (René) van NostrumDep. of Pharmaceutics
Utrecht University
DDF summit, March 12, 2019
©2018 Adare Pharmaceuticals
How-to Use Oral Drug Delivery Technology Innovatively
Luigi BoltriDirector, Technology Development
DDF Berlin, March 11-13, 2019
1
TRANSMUCOSAL DRUG DELIVERYUsing the Mucofilm® technology to bypass the first pass effect
Drug Delivery and Formulation Summit 2019, March 11 – 13, Berlin
Mesoporous Silica DDSAn Option For Liquisolid Drug
Delivery Systems
Fred Monsuur New Business Development and
TCS Manager, Excipients10th Global
New surfactants in wet ball milling and an innovativeembedding of Nanocrystals into a granulate matrixby Dr. Matthias Rischer, Director Drug Delivery & Innovation Projects,Losan Pharma
| 1
Drug Delivery & Formulation Summit, BerlinMarch 12th, 2019
How to use basic principles of Physics in pharmaceutical process development
Application to granulation, coating and drying in Fluid Bed
Sophie MARTINSanofi R&D MontpellierPharmaceutical Sciences Department
Art credit: Close-up of the inhibitor binding site of the colony-stimulating
factor-1 receptor kinase domain.Jacqueline MAXIMILIEN, PhDSenior ScientistSmall Molecule Pharmaceutical Development | Janssen Research & Development, LLC
Control Strategy Approaches in Continuous Manufacturing of Oral Solid Dosage Forms
Drug Delivery Formulation SummitBerlin, March 13th, 2019
| 1
Optimization of industrial freeze drying cycle - Two case studies
DDF 2019
M.Nakach
///////////
Drug DeliveryRecent Technology Trends and Solutions
Dr. Stefan BrachtHead of Disruptive TechnologiesChemical & Pharmaceutical Development
March 11-13th - 2019
Crystallization Kinetics in ASDsChristian Luebbert, Postdoc Pharmaceutical Formulations, TU Dortmund University
Control Strategy Approaches in Continuous Manufacturing of Oral Solid Dosage FormsJacqueline Maximilien, Senior Scientist, Pharmaceutical Development, Janssen Research & Development
Importance of Establishing the Stability of Drug-Loaded NanoparticlesDr. Cornelus F. van Nostrum, Associate Professor, Utrecht University
A Mesoporous Silica DDS – An Option for Liquisolid Drug Delivery SystemsFred Monsuur, New Business Development and TCS Manager, Excipients, GRACE
Smart Delivery of Actives by Polyrotaxanes Providing New Options for the Treatment of Niemann Pick Type C Disease (1)Kerstin Egele, Doctoral Researcher & Gerhard Wenz Professor, Saarland University
Optimization of Industrial Freeze Drying Cycle - Two Case StudiesMostafa Nakach, Head of Pharmaceutical Engineering, Sanofi
How-to Use Oral Drug Delivery Technology InnovativelyLuigi Boltri, Director, Technology Development, Adare Pharmaceuticals
New Surfactants in Wet Ball Milling and an Innovative Embedding of Nanocrystals into a Granulate MatrixDr. Matthias Rischer, Director Drug Delivery & Innovation Projects, Losan Pharma
Polyoxazoline: A Potent Alternative to PEG-Based Formulations of Hydrophobic DrugsProf Rainer Jordan, Chair of Macromolecular Chemistry, School of Science, TU Dresden
Drug Delivery Recent Technology Trends and SolutionsDr. Stefan Bracht, Head of Disruptive Technologies Chemical & Pharmaceutical Development, Bayer
Transmucosal Drug Delivery: Using the Mucofilm® Technology to Bypass the First Pass EffectDr. Sebastian Braun, Head of Science & Technology, tesa Labtec GmbH
How to use Basic Principles of Physics in Pharmaceutical Process Development Application to Granulation, Coating and Drying in Fluid BedSophie Martin, Process Engineer in Pharmaceutical Development, Sanofi
5
11 - 13 March 2019 | Berlin
10th Global
Explore the content – Biologics
Characterization of Subvisible particles Old challenges and newest improvements
Anacelia Ríos Quiroz Roche Biologics Europe Analytical Development and Quality Control Joint Particle Lab End to End Solutions in Freeze Drying:
From Cycle Audit through Formulation, Process Optimisation and Scale up
Dr Mattia CassanelliInternational Technical Sales Executive
Root cause investigations for visible particles and aggregation Case studiesAndreas Seidl, Head Global Analytical Characterization & Bioanalytics, Technical Development Biosimilars
Technical Research & Development / Novartis Global Drug Development
1
HYDROXYLPROPYL ß-CYCLODEXTRIN: A PROMISING EXCIPIENT FOR PROTEIN
STABILIZATION
DDF 2019, BerlinRajeev Gokhale
Trehalose and Sucrose: Essential Components of Platform Biopharma Formulations
Dr. Christian LotzPfanstiehl, Inc.
Dedicated to Better Health
We partner with excellence to improve
therapies for people with serious diseases
DDF Berlin March 11-13th 2019 - H. Audat
Challenges of IV in-use stability for BiologicsSome case studies
Characterization of Subvisible Particles: Old Challenges and Newest ImprovementsAnacelia Ríos Quiroz, Scientist – Group Leader Particle Lab Biologics, Roche
Challenges of IV in-use Stability for Biologics - Some Case StudiesHéloïse Audat, Head of Late Stage Formulation Development Unit, Biologics, Sanofi
Root Cause Investigations for Visible Particles and AggregationAndreas Seidle, Head, Global Analytical Characterisation & Bioanalytics, Technical Development Biosimilars, Novartis
Trehalose and Sucrose: Essential Components of Platform Biopharma FormulationsDr. Christian Lotz, General Manager EMEA, Pfanstiehl GMBH
End to End Solutions in Freeze Drying: From Cycle Audit through Formulation, Process Optimisation and Scale UpDr Mattia Cassanelli, International Technical Sales Executive, Biopharma Group
Hydroxylpropyl ß-Cyclodextrin: A Promising Excipient for Protein StabilizationRajeev Gokhale, Head Global Pharmaceutical Sciences R&D, Head Asia R&D, Roquette
Dedicated to Better HealthEleonora Cerasoli, Senior Research Scientist, Albumedix
“I really appreciated the summit. There was excellent organization, very good
speakers and great talks”Torsten Kneuss, QA Manager Combination Products, Bayer AG
Click on the buttons below to view the presentation slides.
6
11 - 13 March 2019 | Berlin
10th Global
Explore the content – Technology & Innovation
K1 Competence Center - Initiated by the Federal Ministry of Transport, Innovation and Technology (BMVIT) and the Federal Ministry of Digital and Economic Affairs (BMDW).
Funded by the Austrian Research Promotion Agency (FFG), Land Steiermark and the Styrian Business Promotion Agency (SFG).
Digital Design of Pharmaceutical Products and Processes – State of the Art and Challenges
Prof. Johannes Khinast - DDF Summit 2019 - Berlin
Graz University of Technology & Research Center Pharmaceutical Engineering Austria
Click to edit Master title style
• Edit Master text styles• Second level
– Third level– Fourth level
1. Fifth level
Risk Mitigation in Topical Product Development
Dr. Rob TurnerVice President of Business Development and Innovation,
MedPharm Ltd
Challenges and opportunities to include patient centered design in industrial drug development
Dr. Leonie Wagner, Small Molecule Pharmaceutical Development, F. Hoffmann-La Roche
W. L. Gore & AssociatesW. L. Gore & Associates
GORE ImproJect Plunger: A New Option for Delivery of Sensitive Biologics in Pre-Filled Syringes
Russ Hornung, Business Development, W. L. Gore & Associates, Inc .
Re-imagining yourODT Formulation
Introducing a New Lactose Product
SuperTab® 50ODT
Mara van Haandel, MScInnovation Manager, DFE PharmaDDF Berlin, 12 March 2019
Parenteral sustained release of peptides and proteins – getting it right
Simon Bjerregaard
YESTERDAY TODAY TOMORROW
1
Derisking the fill and finish process of biotech productsM.Wacquet, DDF Berlin
March 2019
Progressing the Development of AZD2811 Nanoparticles for Intravenous AdministrationRebecca Booth – Senior Scientist, Pharmaceutical Technology and DevelopmentDrug Delivery and Formulation Summit March 2019
K1 Competence Center - Initiated by the Federal Ministry of Transport, Innovation and Technology (BMVIT) and the Federal Ministry of Science, Research and Economy (BMWFW).Funded by the Austrian Research Promotion Agency (FFG), Land Steiermark and the Styrian Business Promotion Agency (SFG).
Hier “rcpe ppt header Large 01.emf” platzieren
Targeting specific patient populations for distinct oral dosing formulation challenges – flexible technology is key
DDF – Berlin (Germany) – March 13, 2019
Univ.-Prof. Dr. Sven StegemannTechnische Universität Graz
133
March 15, 2019
Solid Dosage Forms for Heterogeneous Patient Groups: Challenges and SolutionsVeronique Henner-KulkarniTechnical Sales ManagerEmail: [email protected]
Early Evaluation of Clinical Performance For Modified Release Products
Dr Carol Thomson (CEO)DDF Summit Berlin 2019
Early Evaluation of Clinical Performance for Modified Release ProductsDr Carol Thomson, Chief Executive Officer, BDD Pharma
HEIDELBERGUNIVERSITY
FUTURE SINCE 1386
Gert Fricker,Institute of Pharmacy and Molecular Biotechnology
Ruprecht-Karls University, Heidelberg [email protected]
IMPACT OF ABC TRANSPORTERS AT THE BLOOD BRAIN BARRIER
DDF SUMMIT 2019
HEIDELBERGUNIVERSITYFUTURE SINCE 1386
Impact of ABC Transporters at the Blood Brain BarrierGert Fricker, Director, Institute of Pharmacy and Molecular Biotechnology, University of Heidelberg
DDF Summit, 11-13 March 2019, Berlin
Miniaturized Capacitive Devices for the Detection of Circulating Biomarkers, Enabling Real-Time Kinetic Measurements, Integrable
with Microfluidic Systems
Federica MantovaniLoredana Casalis
Berkeley, 22 February 2018
1
Miniaturized Capacitive Devices for the Detection of Circulating Biomarkers, Enabling Real-Time Kinetic Measurements, Integrable with Microfluidic SystemsFederica Mantovani, Industrial Liaison, Elettra
DDF Summit
Dr. Franziska Edelmann and Dr. Kishore RavuriRoche Diagnostics GmbH
13th March 2019
Instability of Polysorbates in Protein Biopharmaceutics Instability of Polysorbates in Protein BiopharmaceuticsDr. Franziska Edelmann, Scientist - Pharma Technical Development Analytics, Roche
Digital Design of Pharmaceutical Products and Processes - State of the Art and ChallengesProf. Johannes Khinast, Director, Research Center Pharmaceutical Engineering
Derisking the Fill and Finish Process of Biotech ProductsMarie Wacquet, Drug Product Process Development Unit Manager, Biologics, Sanofi
Progressing the Development of AZD2811 Nanoparticles for Intravenous AdministrationDr Rebecca Booth, Senior Scientist, AstraZeneca
Challenges and Opportunities to Include Patient Centered Design in Industrial Drug DevelopmentLeonie Wagner-Hattler, Formulation Scientist, F. Hoffmann-La Roche
Re-Imagining your ODT FormulationMara van Haandel, Innovation Manager, DFE Pharma
Risk Mitigation in Topical Product DevelopmentRob Turner, Vice President of Business Development and Innovation, MedPharm
Targeting Specific Patient Populations for Distinct Oral Dosing Formulation Challenges – Flexible Technology is KeyProf Dr Sven Stegemann, Director, Pharmaceutical Business Development, Lonza Pharma & Biotech
Solid Dosage Forms for Heterogeneous Patient Groups: Challenges and SolutionsVeronique Henner-Kulkarni, Technical Sales Manager, ShinEtsu
GORE ImproJect Plunger: A New Option for Delivery of Sensitive Biologics in Pre-Filled SyringesRuss Hornung, Business Development, W. L. Gore & Associates
Parental Sustained Release of Peptides and Proteins – Getting it RightSimon Bjerregaard, Senior Research Scientist, Ferring
Click on the buttons below to view the presentation slides.
7
11 - 13 March 2019 | Berlin
10th Global
Explore the content – Device Development
Benefits of early integration of Human Factors: A BYDUREON® BCise case studyJames Meehan, Associate Principal ScientistDDF Summit Berlin March 2019
MICRO-ARRAY PATCHES: DELIVERING HIGH DRUG DOSES TRANSDERMALLY
Professor Ryan F. Donnelly
Predicting the future Learning about challenges with injectable
formulations to select the right primary packaging 10th Global Drug Delivery & Formulation Summit
Berlin, Germany11-13 March 2019
James Mellman, PhD
Simon KervynManager Material Development
March 11th, 2019
Rubber components selection for optimal drug packaging
www.curamdevices.ie
Manita Dangol, Nicky Bertollo, Amy Ni Chuinneagain, Eoin O’Cearbhaill
School of Mechanical and Materials Engineering, University College Dublin, Dublin, Ireland
10th Global Summit Drug Delivery and Formulation (DDF) SummitBerlin, Germany
11th Mar 2019
A Self Anchoring Microneedle Patch (StAMP) offering precise Transdermal Drug Delivery
Facilitating meaningful differentiation of products by establishing a culture of device innovation to support rare disease treatment
March 11th, 2019
• Stefan Holzner• Sr. Director and Head, Device Development, R&D
Shire US Inc., a Takeda company, Lexington, MA, USA
FORMULATION IMPACT ON PATIENT EXPERIENCE: the New Frontier of Large-Volume Subcutaneous Infusion
Mike Hooven, CEO, Enable Injections | DDF Berlin | 11 March 2019
Human Factors Engineering for Medical Device Development
R. Vomscheid, PhDDirector, Devices Development & Technologies - IPSEN
10th Global Drug Delivery& Formulation Summit
March 12, 2019 - BERLIN
///////////
DDF Summit 2019
Benefits and Challenges with Medical Software
2019-03-13 / Torsten Kneuss / Version 1.0
COMBINATION PRODUCTSGLOBAL REGULATORY LANDSCAPE
Viky Verna, MS BME, MS Pharm, RAC
DDF Summit - Berlin
March 11, 2019
© 2019 confinis ag
APRIL KENT
NEW EU MEDICAL DEVICE REGULATION (MDR)NOTIFIED BODY OPINION
REGULATORY AFFAIRS MANAGER, DEVICES12TH MARCH 2019
New EU Medical Device Regulation (MDR) - Notified Body OpinionApril Kent, Regulatory Affairs Manager, Devices, Amgen
Harnessing the Power of the Digital Exhaust and Digital ATM in Wellness Programs
DDF Summit Berlin - March 13, 2019Graham B. Jones
Director of Innovation, Novartis AGProfessor of Medicine, Tufts Medical Center
Thinklabs
Harnessing the Power of the Digital Exhaust and Digital ATM in Wellness ProgramsGraham B Jones, Director of Innovation, Novartis
MDR Impact on pharma companiesBjorg HunterRegulatory Manager, Devices
DDF 2019
MDR Impact on Pharma CompaniesBjorg Hunter, Regulatory Manager, Devices, GSK
Drug Delivery Devices: patient-centered technical and business opportunities -Biosimilars as case-studyCorinna Sonderegger10th Global Drug Delivery and Formulation Summit 2019Berlin, March 11-13, 2019
Global Drug DevelopmentDevice Development & Commercialization
Drug Delivery Devices: Patient-Centered Technical and Business Opportunities – Biosimilars as Case-StudyCorinna Sonderegger, Head Portfolio Management, Device Development & Commercialization, Novartis
Benefits of Early Integration of Human Factors: A BYDURERON BCise Case StudyJames Meehan, Associate Principal Scientist, AstraZeneca
Formulation Impact on Patient ExperienceMike Hooven, CEO, Enable Injections
Human Factors Engineering for Medical Device DevelopmentRémy Vomscheid, Director, Device Development & Technologies, Ipsen
Predicting the Future – Learning about Challenges with Injectable Formulations to Select the Right Primary PackagingJames K. Mellman, Device Manager, Novartis
A Self Anchoring Microneedle Patch (StAMP) Offering Precise Transdermal Drug DeliveryManita Dangol, Senior Research Fellow, University College Dublin
Micro-Array Patches: Delivering High Drug Doses TransdermallyProf Ryan F. Donnelly, Chair in Pharmaceutical Technology, Queen’s University Belfast
Benefits and Challenges with Medical SoftwareTorsten Kneuss, QA Manager Combination Products, Bayer
Combination Products: Global Regulatory LandscapeViky Verna, Co-Founder and VP, confinis
Rubber Components Selection for Optimal Drug PackagingSimon Kervyn, Manager Material Development, Datwyler
Facilitating Meaningful Differentiation of Products by Establishing a Culture of Device Innovation to Support Rare Disease TreatmentStefan Holzner, Senior Director and Head, Device Development, Takeda
Click on the buttons below to view the presentation slides.
8
11 - 13 March 2019 | Berlin
10th Global
Who was there? The summit attracts senior pharmaceutical development and formulation scientists from across industry and academia. Organisations in attendance in 2019 included:
9
10th Global
Who was there?
10th Global
10
Who was there?
10th Global
“Very balanced conference – mix of different fields including small molecules and large molecules. Presence of experts and opportunity to discuss in multiple networking sessions was great”
Sachin Dubey, Head/Deputy Director of Formulation, Analytical and Drug Product Development, Glenmark Pharmaceuticals SA
11
Who was there?
10th Global
Pharmaceuticals Delivery / Formulation Services
Universities
12
By seniority: Scientist/Specialist 28.8% Manager 23.3% Director 20.2% Head 18.1% VP 6.1% C-Level 3.4%
By company type:
Common job functions:
58% 33% 9%
R&D • Analytical Development • Pharmaceutical Development • Formulation Development • Technical Development • Device Development • Process Development • Drug Development • CMC • Human Factors • Innovation • Business Development
1
6
2
5
8
4
9
10
7
3
By country: Top 10 countries:1 Germany 25.1%2 United Kingdom 14.9%3 United States 12.1%4 Switzerland 7.9%5 France 6.5%6 Denmark 5.4%7 Italy 3.9%8 Belgium 3.7%9 Spain 2.8%10 Austria 2.5%
Other countries represented:Netherlands South Korea Finland Japan Greece Ireland Czech Republic India Slovenia
Sweden Poland Portugal Northern Ireland
Norway Romania Taiwan China Hungary
Ghana Croatia Kuwait Macedonia Jordan
Commercial Partners Thank you to our Commercial Partners, without their support the summit couldn’t exist.
Biopharma Groupwww.biopharma.co.uk
Aviviawww.avivia.nl
Ajinomoto Co., Incwww.ajibio-pharma.com
Captisol, a Ligand technologywww.ligand.com
Credence MedSystemswww.credencemed.com
Cambridge Design Partnershipwww.cambridge-design.co.uk
Bosch Packaging Technologywww.boschpackaging.com
Crux Product Designwww.cruxproductdesign.com
Arcinovawww.arcinova.com
Adare Pharmaceuticalswww.adarepharma.com
Armor Pharmawww.armor-pharma.com
ADM-SIOwww.admsio.com
Bachemwww.bachem.com
Albumedixwww.albumedix.com
DFE Pharmawww.dfepharma.com
Datwyler Pharma Packag-ing Internationalwww.datwyler.com
WWW.DDFEVENT.COM | [email protected] | +44 (0) 20 7738 5454
BDD Pharmawww.bddpharma.com
Aquaporinwww.aquaporin.dk
DuPont Nutrition & Healthwww.dupont.com
Confiniswww.confinis.com
11 - 13 March 2019 | Berlin
10th Global
Technological Lac tose Excipients
13
Commercial Partners continued
11 - 13 March 2019 | Berlin
10th Global
leon-nanodrugs GmbHwww.leon-nanodrugs.com
Honeywellwww.honeywell.com
Foster Delivery Sciencewww.deliveryscience.com
LTS Lohmannwww.ltslohmann.de
MedPharmwww.medpharm.com
Losan Pharmawww.losan-pharma.de
Lonza Pharma & Biotechwww.pharma.lonza.com
Merck KGaAwww.merckgroup.com
Gracewww.grace.com
Enable Injectionswww.enableinjections.com
Halo Labswww.halolabs.com
Flexichemwww.flexichem.se
Hovionewww.hovione.com
Intract Pharmawww.intractpharma.com
Frewittwww.frewitt.com
Oakwood Labswww.oakwoodlabs.com
Pensatech Pharmawww.pensatechpharma.com
Munitwww.munit.com
Gamlen Tableting Ltdwww.gamlentableting.com
Lubrizolwww.lubrizol.com
14
Commercial Partners continued
11 - 13 March 2019 | Berlin
10th Global
Pfanstiehl Inc.www.pfanstiehl.com
PMC Isochemwww.pmcisochem.fr
Roquettewww.roquette.com
Shin-Etsu Pharma & Food Materials Distribution GmbHwww.se-pfmd.com
Quotient Scienceswww.quotientsciences.com
Stéarinerie Duboiswww.stearinerie-dubois.com
Sigmund Lindnerwww.sigmund-lindner.com
Precision Nanosystemswww.precisionnanosystems.com
W. L. Gore & Associateswww.gore.com/pharmbio
Upperton Pharma Solutionswww.upperton.com
VELOXwww.velox.com
Worrellwww.worrell.com
Unchained Labswww.unchainedlabs.com
tesa Labtecwww.tesa-labtec.com
Surface Measurement Systemswww.surfacemeasurement systems.com
Commecial Partner Testimonials
15
The flagship DDF Summit will return to Berlin in March
Register as a Delegate
Take advantage of the early registration rates and secure your place now at www.ddfevent.com/book-your-place
Sponsorship Opportunities
Sponsorship is now open for DDF Summit 2020.
If you sell solutions or services in the drug development or delivery space, then get in touch asap. Prime spaces on the agenda and in the exhibition hall always sell out early.
Contact [email protected] for more information.
11th Global
Follow us:#DDFSummit
10th Global
16
